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help them to resume physical activity and to maintain a good
health.
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Purpose: Recent reports have proposed that spontaneous os-
teonecrosis of the knee (SONK) results from a subchondral in-
sufﬁciency fracture. The aim of the study was to assess whether
the onset of SONK in postmenopausal women was related to low
bone mineral density (BMD).
Methods: Twenty ﬁve consecutive postmenopausal women with
SONK in the medial femoral condyle were treated at our institu-
tion during 4 year period between 2005 April to 2009 March. All
patients underwent knee radiograph, knee magnetic resonance
imaging (MRI) and dual energy x-ray absorptiometry at the lum-
bar spine, proximal femur and knee condyles. The patients with
SONK showed typical clinical features including sudden onset and
severe knee pain at the medial femoral condyle. MRI diagnosis of
SONK was based on the presence of a discrete low intensity area
in the femoral condyle on a T1-weighted image. None patients
with SONK had a history of trauma. Patients with SONK which
elapsed more than 12 weeks from onset to all examination were
excluded. Fifty patients with varus knee osteoarthritis (OA) were
also examined as a control. Body mass index was calculated as
an index of obesity. The femorotibial angle was deﬁned as the
lateral angle between the femoral and tibial shaft axes. Clinical ex-
aminations of the knee were documented by use of the American
Knee Society (AKS) Knee Score and Function Score. Differences
BMD values at various points and other data between the groups
were assessed.
Results: The mean age, body mass index and femorotibial angle
in patients with varus knee OA were 69.5±7.3 years, 23.8±3.3
kg/m2 and 179.1±3.0°, respectively. The mean age, body mass
index and femorotibial angle in the patients with SONK were
72.5±6.4 years, 24.7±3.6 kg/m2 and 179.7±2.1°, respectively.
There were no signiﬁcant differences in the mean age, body mass
index and femorotibial angle in the different groups. The mean
AKS Knee Score and Function Score in patients with varus knee
OA were 71.5±17.3 and 75.0±23.6 points, respectively. The mean
AKS Knee Score and Function Score in patients with SONK were
52.2±13.2 and 45.4±15.4 points, respectively. There were sig-
niﬁcant differences in the mean AKS Knee Score and Function
Score in the different groups (p<0.001, p<0.001, respectively).
The mean BMD at the lumbar spine, proximal femur in patients
with varus knee OA were 0.844±0.141 and 0.610±0.096 g/cm2,
respectively. The mean BMD at the lumbar spine, proximal fe-
mur in patients with SONK were 0.785±0.140 and 0.533±0.063
g/cm2, respectively. There was no signiﬁcant difference in the
mean BMD at the lumbar spine in the different groups (p=0.121),
but was signiﬁcant difference in the mean BMD at the proximal
femur in the different groups (p=0.001). The mean BMD at the
medial and lateral condyle of femur and the medial and lateral
condyle of tibia in patients with varus knee OA were 1.028±0.210,
0.700±0.143, 0.819±0.192 and 0.649±0.141 g/cm2, respectively.
The mean BMD at the medial and lateral condyle of femur and
the medial and lateral condyle of tibia in patients with SONK
were 1.012±0.180, 0.567±0.098, 0.748±0.160 and 0.519±0.111
g/cm2, respectively. There were no signiﬁcant differences in the
mean BMD at the medial condyle of femur and medial condyle of
tibia in the different groups (p=0.673, 0.101, respectively), but were
signiﬁcant differences in the mean BMD at the lateral condyle of
femur and lateral condyle of tibia in the different groups (p<0.001,
p<0.001, respectively).
Conclusions: At the ipsilateral lower extremity, BMD of the patient
with SONK was signiﬁcantly lower than BMD of the patients with
varus knee osteoarthritis. Low BMD may be associated with the
onset of SONK in postmenopausal women.
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USEFULNESS OF 7 DAY KNEE PAIN SCORES AMONG
PEOPLE WITH MILD TO MODERATE KNEE OA
PARTICIPATING IN CLINICAL TRIALS
M. Agaliotis, L. Nairn, M. Votrubec, M. Fransen
Univ. of Sydney, Lidcombe, Australia
Purpose: To evaluate the one month changes in knee pain scores
reported by people with mild to moderate knee osteoarthritis (OA)
considering participation in a long term clinical trial evaluating
dietary supplements
Methods: People volunteering for participation in the Long-term
Evauation of Glucosamine Sulphate (LEGS) study, were screened
for symptomatic (knee pain ≥4 out of 10 for most days of the past
month) and radiographic eligibility (medial tibio-femoral joint space
narrowing, but >2mm medial joint space width). If consenting and
eligible, potential study participants were required to complete and
return (mail or fax) a 7 day study Participant Diary during the
pre-randomisation treatment run-in. Participants who proceeded
to randomisation, were required to complete and return another
study Participant Diary. In this Participant Diary, knee pain (left
and right) experienced ‘at its worst’ (range 0-10) is recorded. For
the designated study knee, changes in the mean knee pain (over
7days); Day 1 knee pain and highest knee pain score reported
in one day over the 7 day period were calculated and compared
between the two time periods (pre and post randomisation).
Results: At the end of 2008, 317 participants had been ran-
domised for more than one month. The mean (sd) age of this
cohort was 58 (8) years; 178 (56%) participants were female. Of
the 317 randomised, 285 (90%) had returned the two Participant
Diaries. The mean (sd) days between the pre and post randomi-
sation diaries was 26 (12) days. Despite eligibility criteria requiring
at least moderate pain, the mean (sd) knee pain reported in the
study knee (over 7 days) was 3.5 (2.0), mean (sd) Day 1 knee pain
was 3.5 (2.3) and mean (sd) highest knee pain score in any one
day over the 7 day period was 4.8 (2.2). The correlation between
pre and post randomisation diaries was high for all three calcalu-
ations, 0.71, 0.61 and 0.65 for average, Day 1 and highest knee
pain scores respectively. The mean (sd) decreases in pain scores
between the pre and post randomisation diaries were insigniﬁcant
for all three calculation methods; 0.13 (1.58), 0.12 (2.12) and 0.36
(1.94), respectively
Conclusions:Mild to moderate knee OA has a typically ﬂuctuating
symptomatology. The results indicate that there appears to be no
added beneﬁt of using an average of 7 days of knee pain recording
in clinical trials, when compared with using a single score (Day
1). However, using the highest knee pain score attained over a
7 day period may provide a measurement less inﬂuenced by a
ﬂoor effect and able to detect clinically meaningful symptomatic
beneﬁts for this group of patients.
